Minocycline as a prospective therapeutic agent for cancer and non-cancer diseases: a scoping review
Description
Minocycline is an FDA-approved secondary-generation tetracycline antibiotic. It is a synthetic antibiotic having many biological effects, such as antioxidant, anti-inflammatory, anti-cancer, and neuroprotective functions. This study discusses the
